Page last updated: 2024-08-17

medroxyprogesterone acetate and Choriocarcinoma

medroxyprogesterone acetate has been researched along with Choriocarcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lumbers, ER; Pringle, KG; Wang, Y1
Auchus, RJ; Lee, TC; Miller, WL1

Other Studies

2 other study(ies) available for medroxyprogesterone acetate and Choriocarcinoma

ArticleYear
The effects of cyclic AMP, sex steroids and global hypomethylation on the expression of genes controlling the activity of the renin-angiotensin system in placental cell lines.
    Placenta, 2013, Volume: 34, Issue:3

    Topics: Adult; Azacitidine; Cell Line, Tumor; Choriocarcinoma; Cyclic AMP; DNA Methylation; Drug Therapy, Combination; Estradiol; Female; Gene Expression Regulation, Developmental; Gene Silencing; Humans; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Trimester, First; Renin-Angiotensin System; Trophoblasts

2013
Medroxyprogesterone acetate and dexamethasone are competitive inhibitors of different human steroidogenic enzymes.
    The Journal of clinical endocrinology and metabolism, 1999, Volume: 84, Issue:6

    Topics: Animals; Anti-Inflammatory Agents; Binding, Competitive; Cholesterol Side-Chain Cleavage Enzyme; Choriocarcinoma; Dexamethasone; Enzyme Inhibitors; Humans; Kinetics; Medroxyprogesterone Acetate; Microsomes; Multienzyme Complexes; Pregnenolone; Progesterone Reductase; Radioimmunoassay; Rats; Steroid 17-alpha-Hydroxylase; Steroid Isomerases; Steroids; Tumor Cells, Cultured; Yeasts

1999